Original Research
Published on 23 Nov 2021
Cannabis Use, Schizotypy and Kamin Blocking Performance
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.633476
- 3,417 views
- 3 citations
Type at least 3 characters
551 articles
Review
Published on 23 Nov 2021
Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.784370
- 9,055 views
- 10 citations
Case Report
Published on 22 Nov 2021
Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.786171
- 4,751 views
- 15 citations
Original Research
Published on 18 Nov 2021
A Machine Learning Model to Predict Risperidone Active Moiety Concentration Based on Initial Therapeutic Drug Monitoring
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.711868
- 4,307 views
- 16 citations
Case Report
Published on 17 Nov 2021
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.764112
- 10,500 views
- 22 citations
Clinical Trial
Published on 04 Nov 2021
Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.736822
- 7,666 views
- 3 citations
Original Research
Published on 04 Nov 2021
Genetic Modifiers of Oral Nicotine Consumption in Chrna5 Null Mutant Mice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.773400
- 2,477 views
- 1 citation
Original Research
Published on 04 Nov 2021
Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.732028
- 12,068 views
- 12 citations
Correction
Published on 03 Nov 2021
Corrigendum: Ocimum basilicum (Basil) Modulates Apoptosis and Neurogenesis in Olfactory Pulp of Mice Exposed to Chronic Unpredictable Mild Stress
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.781922
- 1,295 views
Case Report
Published on 27 Oct 2021
Naloxone Alleviate the Severity of Delirium in Hospitalized Patients With Parkinsonism: Three Case Reports
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.748958
- 4,544 views
- 2 citations
Case Report
Published on 25 Oct 2021
Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.683368
- 3,476 views
- 1 citation
Original Research
Published on 21 Oct 2021
Risk of Bleeding Associated With Antidepressants: Impact of Causality Assessment and Competition Bias on Signal Detection
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.727687
- 27,219 views
- 11 citations
Review
Published on 01 Oct 2021
Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.742058
- 13,953 views
- 28 citations
Mini Review
Published on 30 Sep 2021
On Blurry Boundaries When Defining Digital Biomarkers: How Much Biology Needs to Be in a Digital Biomarker?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.740292
- 7,958 views
- 40 citations
Original Research
Published on 29 Sep 2021
Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.728204
- 12,755 views
- 19 citations
Review
Published on 27 Sep 2021
MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.733893
- 21,179 views
- 7 citations